05 Dec 12 28 Nov 16

MSF Urges GAVI to Extend Vaccine Prices to Humanitarian Agencies

The GAVI Alliance should systematically extend the prices it obtains for vaccines to humanitarian actors that are often well placed to reach unvaccinated children, the international medical humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF) said today at the GAVI Partners Forum meeting in Tanzania.

Get Adobe Flash player

Currently, humanitarian actors such as MSF are not able to access these prices, and are left to negotiate access to vaccines on a cumbersome case-by-case basis.

Official estimates place the number of babies not fully vaccinated in 2011 at 22.4 million, which is equivalent to one in five children born each year.

Unvaccinated children

Through its work in unstable contexts and regions that persistently lag behind on vaccination, MSF is often close to children who are under- or unvaccinated.

“We need to be able to act quickly and provide life-saving vaccines to vulnerable children as these opportunities arise,” said Florence Fermon, Head of MSF’s Vaccination Working Group. “We can’t afford unnecessary delays trying to get hold of vaccines through lengthy negotiations.”

MSF has tried in several places to obtain
newer vaccines for use in its projects. In late 2010 and early 2011, it took MSF more than four months of negotiations with the Ministry of Health and pharmaceutical company GlaxoSmithKline to obtain the pneumococcal vaccine for use in its projects in Kenya.

Access to vaccines

MSF Vaccination Campaign in Congo 2012 © Lam Duc Hien/MSF

Such delays form a barrier to increasing access to vaccines for vulnerable children.

MSF has unsuccessfully tried to obtain the pneumococcal vaccine from Pfizer at the GAVI price.
At the core of the problem is that GAVI brokers deals with pharmaceutical companies that exclude other actors from accessing the prices.

These deals often involve prices for vaccines that are still high and unaffordable for countries in the long run.

“We need access to vaccines when we need them, where we need them and at an affordable price,” said Dr. Manica Balasegaram, Executive Director of MSF’s Access Campaign.

“It’s time for GAVI to wake up and recognize that other actors vaccinating on the ground need fast and regular access to life-saving vaccines at the lowest-possible prices.”